/ /

Glaucoma
Autoantibodies may serve as glaucoma ...

The loss of autoantibodies may serve as useful biomarkers for glaucoma, according to Nadine von Thun Und ...

How glucosamine supplements may ...
Biosensors in contact lenses can ...
New technology predicts conversion ...

Latest Issue

::after
::after

OTE Articles

Elbow splinting increases amblyopia patching compliance
Global eye care hope soars with airborne teaching hospital
Confocal scanner gives ophthalmologists valuable new tool
12-month results with small-aperture IOL providing patients with an extended range of vision
Gene therapy trial launched for X-linked retinitis pigmentosaResearchers have injected their first patient with a virus engineered to remodel the gene responsible for X-linked retinitis pigmentosa (XLRP).
Defining dysfunctional lens syndromeRose is a rose is a rose is a rose--a line written (1913) by Gertrude Stein and its variations in a famous quotation are often interpreted as meaning “things are what they are--makes a statement of the law of identity, and in the post-factum age is ever more meaningful. An ophthalmologist could as well write: “Cataract is a cataract is a cataract is a cataract,” ICD-10 Code H25.0 for the diagnosis “Cataracta senilis incipiens” in its earliest stage and notably with a surgical history of more than 2,500 years.
Patients’ health jeopardized by failed ophthalmology follow-upFailure to follow-up after ophthalmology appointments can damage patients’ health, a new study suggests. “In our view, national consideration should be given to create targets for reporting how well providers are managing follow-up patients,” reported A Davis and colleagues in the journal Eye.
Aldehyde dehydrogenase implicated in mucous membrane pemphigoidPreliminary studies suggest disulfiram could aid in the treatment of mucous membrane pemphigoid (MMP). Used topically, the drug may inhibit aldehyde deydrogenase (ALDH), which plays a key role in fibrosis, wrote JK Dart, UCL Institute of Ophthalmology, London.
Evidence weak for blue light-filtering IOLsOnly weak evidence supports the use of IOLs that filter visible blue light, researchers say. “On the basis of currently available evidence, one cannot advocate for the use of blue-light-filtering IOLs over UV-only filtering IOLs,” wroite X. Li, Waterford Institute of Technology, Waterford, Ireland, and colleagues.
No sign of chloramphenicol resistance in bacterial conjunctivitisChloramphenicol remains effective against Gram-positive bacteria, the most common agent in bacterial conjunctivitis, researchers say.